secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001493152-25-025568
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma to present at NobleCon 21 on Dec 3, 2025
---------------------------------------------------------

- CFO/co-CEO James Martin to give Company overview and clinical progress update.
- Presentation at Noble Capital Markets' 21st Emerging Growth Equity Conference on Dec 3, 2025 at 10:00 AM ET.
- Conference held at Florida Atlantic University in Boca Raton, Florida.
- Webcast will be archived for 90 days on Cocrystal's website starting Dec 4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000149315225025568/0001493152-25-025568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000149315225025568/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer